Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma.
Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB.
Yamoah K, et al. Among authors: zaorsky ng.
Brachytherapy. 2014 Sep-Oct;13(5):456-64. doi: 10.1016/j.brachy.2014.04.003. Epub 2014 Jun 18.
Brachytherapy. 2014.
PMID: 24953945